Shots: BI & BioMed X enters into an agreement to develop strategies for early detection of psychiatric disorders The focus of the agreement is for exploring adolescence’s neurobiology for the prevention & development of the psychiatric pathologies such as schizophrenia In 2014, the companies collaborated and have launched three preclinical researches projects for neurology disorders […]Read More
Tags : BioMedX
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US